Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany

Chimeric Antigen Receptors


Chimeric antigen receptor-T cell therapies are poised to become powerful immunotherapeutic tools for combating hematological diseases, which have a pressing need for treatment.

Patients characteristics

Recently, CAR-NK cell therapy has also come be the focus of new treatment options addressing barriers associated with CAR-T cell therapy, such as treatment-induced side effects.

Article Reference link: XX

Scientific article publishing date: 18/11/2020

Article Identifier BSC22_428EN

Creemos en la curación del cáncer desde dentro.

Más información